Proliferation marker securin identifies favourable outcome in invasive ductal breast cancer

@article{Talvinen2008ProliferationMS,
  title={Proliferation marker securin identifies favourable outcome in invasive ductal breast cancer},
  author={Kati A Talvinen and Johannes Tuikkala and Olli S. Nevalainen and Anja Rantanen and Pirkko Hirsim{\"a}ki and Jari Sundstr{\"o}m and Pauliina Kronqvist},
  journal={British Journal of Cancer},
  year={2008},
  volume={99},
  pages={335 - 340}
}
We introduce a new proliferation marker, securin (pituitary tumour-transforming 1 (PTTG1)), analysed in invasive ductal breast carcinomas by cDNA microarrays and immunohistochemistry. In cDNA microarray of a total of 4000 probes of genes, securin was revealed with a significant change in expression among the several proliferation-related genes studied. The value of securin as a proliferation marker was verified immunohistochemically (n=44) in invasive ductal breast cancer. In follow-up analyses… CONTINUE READING
11 Citations
36 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 36 references

Ki-67 as a prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients

  • E de Azambuja, F Cardoso, +7 authors M Paesmans
  • Br J Cancer 96:
  • 2007
1 Excerpt

The prognostic value of proliferation in lymphnodenegative breast cancer patients is age dependent

  • JP Baak, PJ vanDiest, +5 authors E Gudlaugsson
  • Eur J Cancer
  • 2007
1 Excerpt

Long-term survival of T1 and T2 lymph node-negative breast cancer patients according to Mitotic Activity Index: a population-based study

  • WJ Louwman, MW van Beek, +4 authors JW Coebergh
  • Int J Cancer 118:
  • 2006
1 Excerpt

Similar Papers

Loading similar papers…